Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Tobira Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| Tobira Therapeutics, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| Tobira Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| Tobira Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| Tobira Therapeutics, Inc., Medical Devices Deals, 2010 to YTD 2016 | 9 | 1 |
| Tobira Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 10 | 2 |
| Tobira Therapeutics, Inc., Pharmaceuticals &Healthcare, Deal Details | 12 | 28 |
| Venture Financing | 12 | 1 |
| Regado Biosciences Raises US$51 Million In Series E Financing | 12 | 2 |
| Regado Biosciences Raises US$6.8 Million In Venture Financing | 14 | 1 |
| Regado Biosciences Secures US$11.6 Million In Financing | 15 | 1 |
| Tobira Therapeutics Secures US$31 Million In Series B Round Of Financing | 16 | 2 |
| Tobira Therapeutics Secures US$4 Million In Venture Financing | 18 | 1 |
| Regado Biosciences Raises US$14.55 Million In Venture Financing | 19 | 1 |
| Merger | 20 | 1 |
| Regado Biosciences Merges with Tobira Therapeutics | 20 | 2 |
| Licensing Agreements | 22 | 1 |
| Tobira Therapeutics Enters into Licensing Agreement with Dong-A for Evogliptin | 22 | 2 |
| Dong-A Enters into Licensing Agreement with Tobira Therapeutics for Cenicriviroc | 24 | 1 |
| Equity Offering | 25 | 1 |
| Tobira Therapeutics Withdraws Registration Statement for Private Placement of Shares for up to USD40 Million | 25 | 1 |
| Tobira Therapeutics Raises USD27 Million in Private Placement of Shares | 26 | 2 |
| Tobira Therapeutics Withdraws IPO | 28 | 2 |
| Regado Biosciences Completes Public Offering Of Shares For US$60 Million | 30 | 2 |
| Regado Biosciences Completes Private Placement Of Shares For US$20 Million | 32 | 1 |
| Regado Biosciences Completes Underwriters' Exercise Of Over-Allotment Option For IPO For US$43 Million | 33 | 2 |
| Debt Offering | 35 | 1 |
| Tobira Therapeutics Raises USD13 Million in Private Placement of Notes | 35 | 2 |
| Acquisition | 37 | 1 |
| Allergan to Acquire Tobira Therapeutics in Tender Offer | 37 | 3 |
| Tobira Therapeutics, Inc. - Key Competitors | 40 | 1 |
| Key Employees | 41 | 1 |
| Locations And Subsidiaries | 42 | 1 |
| Head Office | 42 | 1 |
| Appendix | 43 | 1 |
| Methodology | 43 | 1 |
| About GlobalData | 43 | 1 |
| Contact Us | 43 | 1 |
| Disclaimer | 43 | 1 |